Rehg J - Search Results

1

MN1-TEL, the product of the t(12;22) in human myeloid leukemia, immortalizes murine myeloid cells and causes myeloid malignancy in mice.

Carella C, Bonten J, Rehg J, Grosveld GC. Carella C, et al. Among authors: rehg j. Leukemia. 2006 Sep;20(9):1582-92. doi: 10.1038/sj.leu.2404298. Epub 2006 Jun 29. Leukemia. 2006. PMID: 16810199

2

The ETS factor TEL2 is a hematopoietic oncoprotein.

Carella C, Potter M, Bonten J, Rehg JE, Neale G, Grosveld GC. Carella C, et al. Among authors: rehg je. Blood. 2006 Feb 1;107(3):1124-32. doi: 10.1182/blood-2005-03-1196. Epub 2005 Oct 18. Blood. 2006. PMID: 16234363 Free PMC article.

3

Differential effects of targeted disruption of thiopurine methyltransferase on mercaptopurine and thioguanine pharmacodynamics.

Hartford C, Vasquez E, Schwab M, Edick MJ, Rehg JE, Grosveld G, Pui CH, Evans WE, Relling MV. Hartford C, et al. Among authors: rehg je. Cancer Res. 2007 May 15;67(10):4965-72. doi: 10.1158/0008-5472.CAN-06-3508. Cancer Res. 2007. PMID: 17510427

4

EWS/FLI-1 induces rapid onset of myeloid/erythroid leukemia in mice.

Torchia EC, Boyd K, Rehg JE, Qu C, Baker SJ. Torchia EC, et al. Among authors: rehg je. Mol Cell Biol. 2007 Nov;27(22):7918-34. doi: 10.1128/MCB.00099-07. Epub 2007 Sep 17. Mol Cell Biol. 2007. PMID: 17875932 Free PMC article.

5

Disruption of T-cell differentiation precedes T-cell tumor formation in LMO-2 (rhombotin-2) transgenic mice.

Neale GA, Rehg JE, Goorha RM. Neale GA, et al. Among authors: rehg je. Leukemia. 1997 Apr;11 Suppl 3:289-90. Leukemia. 1997. PMID: 9209368

6

Activity of the multikinase inhibitor sorafenib in combination with cytarabine in acute myeloid leukemia.

Hu S, Niu H, Inaba H, Orwick S, Rose C, Panetta JC, Yang S, Pounds S, Fan Y, Calabrese C, Rehg JE, Campana D, Rubnitz JE, Baker SD. Hu S, et al. J Natl Cancer Inst. 2011 Jun 8;103(11):893-905. doi: 10.1093/jnci/djr107. Epub 2011 Apr 12. J Natl Cancer Inst. 2011. PMID: 21487100 Free PMC article.

7

Development of Mast Cell and Eosinophil Hyperplasia and HLH/MAS-Like Disease in NSG-SGM3 Mice Receiving Human CD34+ Hematopoietic Stem Cells or Patient-Derived Leukemia Xenografts.

Janke LJ, Imai DM, Tillman H, Doty R, Hoenerhoff MJ, Xu JJ, Freeman ZT, Allen P, Fowlkes NW, Iacobucci I, Dickerson K, Mullighan CG, Vogel P, Rehg JE. Janke LJ, et al. Among authors: rehg je. Vet Pathol. 2021 Jan;58(1):181-204. doi: 10.1177/0300985820970144. Epub 2020 Nov 19. Vet Pathol. 2021. PMID: 33208054 Free PMC article.

8

A gene transfer strategy for making bone marrow cells resistant to trimetrexate.

Spencer HT, Sleep SE, Rehg JE, Blakley RL, Sorrentino BP. Spencer HT, et al. Among authors: rehg je. Blood. 1996 Mar 15;87(6):2579-87. Blood. 1996. PMID: 8630426 Free article.

9

Prospective isolation of murine hematopoietic stem cells by expression of an Abcg2/GFP allele.

Tadjali M, Zhou S, Rehg J, Sorrentino BP. Tadjali M, et al. Among authors: rehg j. Stem Cells. 2006 Jun;24(6):1556-63. doi: 10.1634/stemcells.2005-0562. Epub 2006 Feb 16. Stem Cells. 2006. PMID: 16484343

10

Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis.

Inoue K, Wen R, Rehg JE, Adachi M, Cleveland JL, Roussel MF, Sherr CJ. Inoue K, et al. Among authors: rehg je. Genes Dev. 2000 Jul 15;14(14):1797-809. Genes Dev. 2000. PMID: 10898794 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

215 results

Search Page

Filters